Cell Therapy Industry HiLites 2009-04-10
Here we are in April 2009. The much newly anticipated date when we expect the Dendreon saga to head toward a climax. Few people know the Dendreon story better then Xconomy journalist, Luke Timmerman Continue Reading
Somatic Cell Therapy for Cardiac Disease: FDA issues a new draft guidance
FDA has issued a new draft guidance entitled "Somatic Cell Therapy for Cardiac Disease".The guidance is intended to provide sponsors who are developing cellular therapies for the treatment of cardiac Continue Reading
Cell types available for regenerative medicine applications
A useful teaching image and an article that's recommended reading:Cell types available for regenerative medicine applications.Click on image to view larger version.Excerpted from: Stem cell Continue Reading
Another imminent M&A in cell therapy?
Is another company with commercial cell therapy products about to be bought for a song?York Pharma PLC (AIM:YRK) is a pharmaceutical Group established in 2003 specializing in the acquisition, Continue Reading
CIRM & friends join efforts for one-day focus on translating stem cells into products
This is my public service announcement for the week. ISCT continues to stack on the value to it's annual meeting this year in San Diego with the recent announcement that ISCT, CIRM, and ISSCR are Continue Reading
Will the real regenmed association please stand up?
Further to my post on this topic back in September last year and ongoing discussions I have been having, I have decided to create a quick 4-question poll to get your opinion.I am not representing Continue Reading
Cell Therapy Stimulus Opportunities
There are some real, imminent stimulus funding opportunities related to cell therapy that offer up to $1 million in funding over 2 years for up to 200 projects all to be handed out quite quickly. If Continue Reading
